Position in ABBV
as of Jun 30, 2026
· filed Jul 24, 2026
Position Value
$4,997,318
+$495,493 QoQ
Shares Held
19,859
-4.1% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
1.61%
of 13F equity value
Holder Rank
#1,317
of 4,153 holders
Holding Since
Jun 2020
25 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Intrua Financial, LLC holds $17,604,029 across 11 Drug Manufacturers - General names. ABBV ranks #1 (28.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
This page
|
19,859 | $4,997,318 | |
| 2 | LLY |
ELI LILLY & Co
|
2,244 | $2,691,521 | |
| 3 | JNJ |
Johnson & Johnson
|
10,446 | $2,652,970 | |
| 4 | AMGN |
Amgen Inc
|
5,070 | $1,835,948 | |
| 5 | PFE |
Pfizer Inc
|
65,137 | $1,568,498 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
19,442 | $1,120,248 | |
| 7 | GSK |
GSK plc
|
16,873 | $884,482 | |
| 8 | MRK |
Merck & Co., Inc.
|
6,787 | $872,129 |
All Filings in ABBV
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,997,318 | 19,859 | Shares | Sole | 2026-07-24 | |
| 2026-03-31 | $4,501,825 | 20,699 | Shares | Sole | 2026-04-23 | |
| 2025-12-31 | $4,772,013 | 20,885 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $5,164,962 | 22,307 | Shares | Sole | 2025-10-29 | |
| 2025-06-30 | $3,847,160 | 20,726 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $4,245,503 | 20,263 | Shares | Sole | 2025-05-28 | |
| 2024-12-31 | $3,900,692 | 21,951 | Shares | Sole | 2025-05-28 | |
| 2024-09-30 | $4,332,513 | 21,939 | Shares | Sole | 2025-05-28 | |
| 2024-06-30 | $4,562,260 | 26,599 | Shares | Sole | 2025-05-28 | |
| 2024-03-31 | $4,785,405 | 26,279 | Shares | Sole | 2025-05-28 | |
| 2023-12-31 | $3,995,746 | 25,784 | Shares | Sole | 2025-05-28 | |
| 2023-09-30 | $3,173,338 | 21,289 | Shares | Sole | 2025-05-28 | |
| 2023-06-30 | $2,814,105 | 20,887 | Shares | Sole | 2025-02-13 | |
| 2023-03-31 | $2,034,676 | 12,767 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $2,180,118 | 13,490 | Shares | Sole | 2023-01-20 | |
| 2022-09-30 | $1,795,998 | 13,382 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $2,030,595 | 13,258 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $2,191,402 | 13,518 | Shares | Sole | 2022-05-11 | |
| 2021-12-31 | $1,245,815 | 9,201 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $1,056,047 | 9,790 | Shares | Sole | 2021-10-28 | |
| 2021-06-30 | $704,225 | 6,252 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $723,450 | 6,685 | Shares | Sole | 2021-04-30 | |
| 2020-12-31 | $443,065 | 4,135 | Shares | Sole | 2021-02-03 | |
| 2020-09-30 | $361,659 | 4,129 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $594,087 | 6,051 | Shares | Sole | 2020-08-14 | |
| No filing history on record for this holder in this stock. | ||||||